VACCELERATE Latest News

New Scientific VACCELERATE Publication

08.10.2022 / A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network (Trials): https://trebuchet.public.springernature.app/get_content/29c30f05-5202-4419-a257-e7f84bd41444

Upcoming VACCELERATE Webinar

DECEMBER 7th 14.00-15.00 (CET)

Intentions to get vaccinated against Monkeypox in Healthcare workers in France and Belgium 4 correlates with attitudes toward COVID-19 vaccination with Amandine Gagneux-Brunon 

Registration: https://uni-koeln.zoom.us/meeting/register/tJAtfu2vpjIjG9H_yXiewgsBEhGriAPWRhOD

VACCELERATE Newsletters

We are happy to send you the pdf versions of our newsletters including the links providing further information on the topics: info@vaccelerate.eu. 

NEWSLETTER Issue II/2022

Published in September 2022. 

NEWSLETTER Issue I/2022

Published in July 2022. 

VACCELERATE Press Releases

19.09.2022 / VACCELERATE Network Supports Diagnostics and Treatment of Monkeypox: https://twitter.com/vaccelerate_eu/status/1571924880295084033

29.08.2022 / Lietuvoje jau veikia VACCELERATE savanorių dalyvauti klinikiniuose tyrimuose registras: https://www.santa.lt/lietuvoje-jau-veikia-vaccelerate-savanoriu-dalyvauti-klinikiniuose-tyrimuose-registras/

25.08.2022 / First children participate in UMC Utrecht-led study: Is one COVID-19 vaccination dose enough for kids? https://twitter.com/vaccelerate_eu/status/1562848995793596416

28.07.2022 / The VACCELERATE Volunteer Clinical Trial Registry is launched in Italy: https://twitter.com/vaccelerate_eu/status/1556578444850434055

21.07.2022 / How many COVID-19 infections are there in Germany? Pilot study in Cologne investigates high dark figure: https://twitter.com/vaccelerate_eu/status/1550014216635023360 (German translation: https://twitter.com/CornelyOliver/status/1550015496413745152)

15.03.2022 / VACCELERATE study on the effectiveness of a second booster shot begins in Ireland: https://twitter.com/vaccelerate_eu/status/1503688207506063360

22.02.2022 / Karolinska Universitetssjukhuset söker fler deltagare i kampen mot framtida pandemier: Karolinska Universitetssjukhuset söker fler deltagare i kampen mot framtida pandemier – Karolinska Universitetssjukhuset (cision.com)

16.02.2022 / Wer sollte wann weiteren Booster bekommen?: https://www.uk-koeln.de/de/uniklinik-koeln/aktuelles/detailansicht/wer-sollte-wann-weiteren-booster-bekommen/

05.11.2021 / Studie zur Wirksamkeit der „Boosterimpfung“ gegen Corona startet: https://portal.uni-koeln.de/universitaet/aktuell/presseinformationen/detail/studie-zur-wirksamkeit-der-boosterimpfung-gegen-corona-startet

22.07.2021 / Coronavirus: Commission steps up research funding with €120 million for 11 new projects to tackle the virus and its variants (European Commission): https://ec.europa.eu/commission/presscorner/detail/en/IP_21_3803

12.04.2021 / Cologne’s university medicine to coordinate EU vaccine research network (Coimbra Group): https://newsletters.coimbra-group.eu/t/ViewEmail/j/4AD409F80C7A2CCF2540EF23F30FEDED/4013911B0F09E5BE4AB3169DA1FD82E9

16.03.2021 COMBACTE To Support Vaccine Trial Network VACCELERATE (Combacte): https://www.combacte.com/news/combacte-support-vaccine-trial-network-vaccelerate/

15.03.2021 / 12 Million for European COVID-19 Vaccine Research (Combacte): https://www.combacte.com/news/12-million-european-covid-vaccine-research/

18.02.2021 / Neues Konsortium koordiniert EU-Impfstoff-Forschungsnetzwerk: https://www.uk-koeln.de/uniklinik-koeln/aktuelles/detailansicht/neues-konsortium-koordiniert-eu-impfstoff-forschungsnetzwerk/

18.02.2021 / Cologne’s university medicine to coordinate EU vaccine research network VACCELERATE (CECAD): https://www.cecad.uni-koeln.de/about/news/article/colognes-university-medicine-to-coordinate-eu-vaccine-research-network-vaccelerate/

17.02.2021 / EU to invest €150 million for research to counter coronavirus variants (European Commission): https://ec.europa.eu/info/news/eu-invest-eu150-million-research-counter-coronavirus-variants-2021-feb-17_en

VACCELERATE Press Review

23.11.2022 / Výzkumná síť VACCELERATE: staňte se součástí výzva registru dobrovolníků (MUNI MED): https://www.med.muni.cz/aktuality/vyzkumna-sit-vaccelerate-stante-se-soucasti-vyzva-registru-dobrovolniku

10.10.2022 / Corona-Pandemie wurde zum Booster für Vakzinologie (K.AT News): https://k.at/news/corona-pandemie-booster-fuer-vakzinologie/402175785

20.09.2022 / Η Ελλάδα στον χάρτη των κλινικών δοκιμών εμβολίων κατά της CoViD (Iatronet): https://www.iatronet.gr/article/111645/h-ellada-ston-harth-ton-klinikon-dokimon-emvolion-kata-ths-covid

28.07.2022 / Nasce in Italia „VACCELERATE“, il registro degli studi clinici volontari: Verona è capofila nazionale (Mattino Verona): https://www.mattinodiverona.it/2022/07/28/nasce-in-italia-vaccelerate-il-registro-degli-studi-clinici-volontari-lunivr-riferimento-nazionale-del-progetto/

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Lafreccia): https://www.lafrecciaweb.it/2022/07/28/partecipare-a-studi-su-prodotti-anti-pandemie-al-via-registro-volontari-progetto-ue-parte-anche-in-italia-universita-verona-centro-di-riferimento-nazionale/

28.07.2022 / Nasce in Italia „VACCELERATE“, il registro degli studi clinici volontari: Verona è capofila nazionale (In salute news): https://www.insalutenews.it/in-salute/nasce-in-italia-vaccelerate-il-registro-degli-studi-clinici-volontari-universita-di-verona-riferimento-nazionale/

28.07.2022 / Covid: attivo in Italia registro volontari „VACCELERATE“ Database permette di aderire a progretti sul vaccino (Federfarma): https://federfarma.it/Edicola/Ansa-Salute-News/VisualizzaNews.aspx?type=Ansa&key=33884

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Corriere Del Umbria): https://corrieredisiena.corr.it/news/adnkronos/32566212/partecipare-a-studi-su-prodotti-anti-pandemie-al-via-registro-volontari.html

28.07.2022 / L'università di Verona riferimento nazionale del Registro degli studi clinici volontari „VACCELERATE“ (Primoweb): https://primoweb.it/luniversita-di-verona-riferimento-nazionale-del-registro-degli-studi-clinici-volontari-vaccelerate/

28.07.2022 / Arriva in Italia registro die volontari per participare a studi clinici sui vaccini (Veronasera): https://www.veronasera.it/attualita/registro-volontari-vaccini-vaccelerate-28-luglio-2022.html

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Olbia Notizie): https://www.olbianotizie.it/24ore/articolo/632005-partecipare_a_studi_su_prodotti_anti_pandemie_al_via_registro_volontari

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Tiscali News): https://notizie.tiscali.it/salute/articoli/partecipare-studi-prodotti-anti-pandemie-via-registro-volontari-00001/?chn

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Affaritaliani): https://www.affaritaliani.it/rubriche/tuttasalute/notiziario/partecipare-a-studi-su-prodotti-anti-pandemie-al-via-registro-volontari-277113.html

28.07.2022 / Nasce in Italia „VACCELERATE“, il registro degli studi clinici volontari: Verona è capofila nazionale (A Salute & Benessere): https://www.larena.it/rubriche/salute-e-benessere/nasce-in-italia-vaccelerate-il-registro-degli-studi-clinici-volontari-verona-e-capofila-nazionale-1.9543801

26.07.2022 / UMC Utrecht is investigating whether one corona jab in children works just as well as two (Time.News): https://time.news/umc-utrecht-is-investigating-whether-one-corona-jab-in-children-works-just-as-well-as-two/

26.07.2022 / Onderzoek naar 1 of 2 coronaprikken bij kinderen (UMC Utrecht): https://www.umcutrecht.nl/nieuws/onderzoek-naar-1-of-2-coronaprikken-bij-kinderen

27.03.2022 / Antibodies could determine fourth vaccine eligibility – study: https://www.rte.ie/news/coronavirus/2022/0327/1288742-coronavirus-antibodies/

24.01.2022 / VACCELERATE: Volunteer Registry: A European Study Participant Database to Facilitate Clinical Trial Enrolment (THE LANCET Preprint): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4016606

06.01.2022 / Nach dem Booster: Brauchen wir bald noch eine vierte Impfung gegen Corona? (Kölner Stadt-Anzeiger): https://www.ksta.de/ratgeber/gesundheit/nach-dem-booster-brauchen-wir-bald-noch-eine-vierte-impfung-gegen-corona–39359316

19.12.2021 / Die Vierte Impfung. Impfstoff gegen Omikron (Zeit): https://www.zeit.de/gesundheit/2021-12/omikron-variante-impfstoff

13.12.2021 / Mehrere Impfversuche bei initialen Non-Respondern machen“ (Ärzteblatt): https://www.aerzteblatt.de/nachrichten/129957/Mehrere-Impfversuche-bei-initialen-Non-Respondern-machen

08.12.2021 / Interview with Zoi D. Pana about the situation in Cyprus and the VACCELERATE network (Offsite): https://www.offsite.com.cy/eidiseis/topika/pana-gia-vaccelerate-den-kanei-toys-anthropoys-peiramatozoa

03.12.2021 / Interview with Oliver Cornely and Zoi D. Pana (Alpha Channel CY): https://twitter.com/vaccelerate_eu/status/1468558210437165059

23.11.2021 / Interview „Seit März 2020 im Lockdown“ (Kölner Stadt-Anzeiger): Print

15.11.2021 / Lietuvoje pradėtas COVID-19 stiprinamosios vakcinos dozės tyrimas (Lrytas): https://www.lrytas.lt/it/laboratorija/2021/11/15/news/lietuvoje-pradetas-covid-19-stiprinamosios-vakcinos-dozes-tyrimas-21407670

15.11.2021 / Pradėtas COVID-19 stiprinamosios vakcinos dozės tyrimas (Santaros Klinikos): https://www.santa.lt/naujienos/pradetas-covid-19-stiprinamosios-vakcinos-dozes-tyrimas/

12.11.2021 / Studie untersucht Booster-Effekt (Kölnische Rundschau): Print

12.11.2021 / Uni Köln Studie untersucht Booster-Effekt der Corona-Impfungen (Kölnische Rundschau): Uni Köln: Studie untersucht Booster-Effekt der Corona-Impfungen | Kölnische Rundschau (rundschau-online.de)

09.11.2021 / Studie zur Wirksamkeit der Booster-Impfung (Frankfurt Live): https://www.frankfurt-live.com/studie-zur-wirksamkeit-der-booster-impfung-136942.html

08.11.2021 /Neue Studie startet in Köln Wie gut sind Booster-Impfungen wirklich? (Kölner Stadt-Anzeiger): https://www.ksta.de/koeln/neue-studie-startet-in-koeln-wie-gut-sind-booster-impfungen-wirklich–39112684

03.11.2021 / Alle Infos zur Auffrischung Wann kann ich mir die Booster-Impfung gegen Corona holen? (Kölner Stadt-Anzeiger): Booster-Impfung: Wer braucht die dritte Impfdosis? | Kölner Stadt-Anzeiger (ksta.de)

26.10.2021 / Nach Kimmich-Aussage Was Experten zu Langzeitfolgen der Corona-Impfung sagen (Kölner Stadt-Anzeiger): https://www.ksta.de/ratgeber/gesundheit/nach-kimmich-aussage-was-experten-zu-langzeitfolgen-der-corona-impfung-sagen-39087508

25.10.2021 / Uniklinik Köln sucht Probanden für Drittimpfung (WDR): TV

13.10.2021 / Studie zur Wirksamkeit der Booster-Impfung (Radio Köln): Radio

28.09.2021 / Zu langsam, zu mühsam, zu wenig (SZ): Print

27.09.2021 / Der geringe Beitrag der deutschen COVID-19-Forschung (Tagesspiegel): Print 

16.07.2021 / ECCMID 2021 TV: Talking trials with Oliver Cornely (ECCMID TV): https://www.youtube.com/watch?v=cKRC_2wYXEU

10.07.2021 / Hunderte Kölner trotz zweiter Impfung infiziert (Kölner Stadt-Anzeiger): Print

09.07.2021 / Zu wenig Antikörper? Was wir über die COVID-19-Todesfälle bei geimpften Kölnern wissen? (Kölner Stadt-Anzeiger)

30.06.2021 / Coronavirus: Government advisor part of €12m grant for Covid vaccine research (Cyprus Mail): https://cyprus-mail.com/2021/06/30/coronavirus-government-advisor-part-of-e12m-grant-for-covid-vaccine-research/

27.05.2021 / Aufholjagd: Das europäische Impfstoff-Netzwerk Vaccelerate (ARTE): https://www.arte.tv/de/videos/104080-000-A/aufholjagd-das-europaeische-impfstoff-netzwerk-vaccelerate/

12.05.2021 / Expert says at least one booster vaccine shot necessary (in-Cyprus): https://in-cyprus.philenews.com/expert-says-at-least-one-booster-vaccine-shot-necessary/

11.04.2021 / Pulse of Europe Rheinland: „Europa – Gesundheitspolitik für eine krisenfeste Zukunft?“ (Event): https://www.youtube.com/watch?v=NLR-ELvSyxo

14.03.2021 / 11.111 – VACCELERATE Volunteer Registry (Kölner Universitätsmagazin): https://portal.uni-koeln.de/universitaet/aktuell/koelner-universitaetsmagazin/unimag-einzelansicht/11111

VACCELERATE-related Scientific Publications

11.2022 / Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination (Journal of Immunological Methods): https://www.sciencedirect.com/science/article/pii/S0022175922001326?via%3Dihub

10.2022 / Monkeypox diagnostic and treatment capacity at epidemic onset: A VACCELERATE online survey (Journal of Infection and Public Health): https://www.sciencedirect.com/science/article/pii/S1876034122002118?via%3Dihub

08.10.2022 / A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network (Trials): https://pubmed.ncbi.nlm.nih.gov/36209129/

19.09.2022 / Monkeypox in children and adult women in Europe: Results from a flash VACCELERATE pilot survey (Enfermedades Infecciosas y Microbiología Clínica): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534071/

31.08.2022 / Vaccination rates in Europe are not associated with online media intensity (JCOM Journal of Science Communication): https://jcom.sissa.it/archive/21/05/JCOM_2105_2022_A05

18.06.2022 / A pilot surveillance report of SARS-CoV-2 rapid antigen test results among volunteers in Germany, 1^st week of July 2022 (Infection): https://link.springer.com/article/10.1007/s15010-022-01931-7

02.06.2022 / VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment (Vaccine): https://www.sciencedirect.com/science/article/pii/S0264410X22006053?via%3Dihub

11.01.2022 / Factors that impact on recruitment to vaccine trials during a pandemic or epidemic: a qualitative evidence synthesis (Cochrane Library): https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000065/full

29.07.2021 / Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 (The Lancet Infectious Diseases): https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00420-5/fulltext

27.05.2021 / Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS) (The Lancet): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233007/

VACCELERATE Events

1st Scientific Meeting of the National CY Vaccination Committee 

22 October 2022, Cyprus

MYK 2022

12-14 September 2022 Vienna, Austria

CZECRIN Annual Research Conference 2022 

09 JUNE 2022 Brno, Czech Republic

International Clinical Trials Day (ICTD) 2022

17 MAY 2022 Berlin, Germany

FAMHP Vaccine Symposium

10 May 2022

Prof. Pierre Van Damme presenting VACCELERATE in his talk „Perspective for the future: Vaccinopolis and biopreparedness initiative“

40th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) 

09-13 MAY 2022 Athens, Greece

23-26 APRIL 2022

32nd European Congress of Clinical Microbiology & Infectious Diseases, Lisbon, Portugal

1st Cypriot-Greek VACCELERATE Volunteer Registry Webinar with local National Patient Advocacy Groups 28 MARCH 2022

– To seek the support of PAG Members in completing the VAC PAG questionnaire (perspectives of PAGs for participation in clinical trials and volunteer registries)

– To invite them to join the VACCELERATE Volunteer Registry by becoming volunteers in our Cypriot Greek VAC platforms More than 12 PAGs participated

You can watch the video of the webinar (in Greek) here: https://www.youtube.com/watch?v=DNFNVe17mtg

The First World Conference Fighting COVID-19 Pandemic Health Challenges

26-28 MARCH 2022, Belgrade, Serbia.

VACCELERATE talk: Jon Salmanton-García: VACCELERATE: The pan-European backbone for the acceleration of phase 2 & 3 COVID-19 vaccine trials

1st VACCELERATE Annual Meeting 09-10 MARCH 2022

With a keynote lecture by top leading expert Stephen Lockhart  from Pfizer:
Vaccine Clinical Trials: Key Factors for Success – BNT162 as an Example.